Building Community Partnerships In Advanced Heart Failure Therapies: A Multidisciplinary Approach
Area Cardiologists, Cardiovascular surgeons, Vascular Medicine Doctors, Vascular Surgeons, Electrophysiologists, Internal Medicine Doctors, Intensivists, APPs and mid-level providers.
- To be able to identify a patient that could benefit from Advanced Heart Failure Therapies
- Understand the differences between medical management, mechanical support and transplant, along with identifying factors on when to refer a patient for evaluation
- Understand the differences between bridge-to-transplant, destination therapy and transplant
5:00 – 5:45 PM - mingling with butler passed hors d’oeuvres and cocktails.
5:45 PM - Seated for dinner
6:30 PM - Dessert is served
6:30 – 6:45 PM – Dr. Mathier – Advanced Heart Failure Therapies Introduction
6:45 – 7:00 PM – Dr. Keebler – How to Save a Life: Identifying and Treating Advanced Heart Failure in 2019
7:00 – 7:15 PM – Dr. Sciortino – Surgical aspect: VAD vs. Heart Transplant
7:15 – 7:20 PM Questions
7:20 PM – Dr. Mathier introduces Richard McClelland – VAD Patient – NO CME credit awarded
7:25 – 7:45 PM - Mr. McClelland speaks – No CME credit awarded
7:45 PM – Michael Mathier, MD - Final questions, discussion and wrap-up
8:00 PM – Adjournment
Mary Keebler, MD
Medical Director, Advanced Heart Failure
Program, UPMC, Pittsburgh, PA
Michael Mathier, MD
Director, Section of Heart Failure and
Pulmonary Hypertension, UPMC, Pittsburgh, PA
Christopher Sciortino, MD, PhD
Surgical Director, Advanced Heart Failure
Program, UPMC, Pittsburgh, PA
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
- Mary Keebler, MD is a consultant for Medtronic.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 Attendance